moxifloxacin has been researched along with alizarin in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (alizarin) | Trials (alizarin) | Recent Studies (post-2010) (alizarin) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 584 | 4 | 295 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahl, P; Hu, DN; Koplin, RS; McCormick, S; Meskin, SW; Ritterband, DC; Seedor, JA; Shah, MK; Shao, S; Shapiro, DE | 1 |
1 other study(ies) available for moxifloxacin and alizarin
| Article | Year |
|---|---|
Efficacy and safety of moxifloxacin as an additive in Optisol-GS a preservation medium for corneal donor tissue.
Topics: Anthraquinones; Anti-Infective Agents; Aza Compounds; Cell Count; Cell Survival; Chondroitin Sulfates; Coloring Agents; Complex Mixtures; Cornea; Culture Media, Serum-Free; Dextrans; Drug Combinations; Endothelium, Corneal; Fluoroquinolones; Gentamicins; Humans; Middle Aged; Moxifloxacin; Organ Preservation; Organ Preservation Solutions; Quinolines; Tissue Donors; Trypan Blue | 2006 |